1. Home
  2. ASLE vs LAB Comparison

ASLE vs LAB Comparison

Compare ASLE & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.31

Market Cap

296.8M

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.91

Market Cap

354.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASLE
LAB
Founded
2008
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
296.8M
354.1M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
ASLE
LAB
Price
$6.31
$0.91
Analyst Decision
Hold
Hold
Analyst Count
2
1
Target Price
$7.00
$1.35
AVG Volume (30 Days)
271.7K
1.8M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
61.54
EPS
0.18
N/A
Revenue
$335,286,000.00
$101,937,000.00
Revenue This Year
$23.41
N/A
Revenue Next Year
$6.80
$2.63
P/E Ratio
$35.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$0.88
52 Week High
$9.08
$1.72

Technical Indicators

Market Signals
Indicator
ASLE
LAB
Relative Strength Index (RSI) 42.22 34.74
Support Level $5.67 N/A
Resistance Level $6.56 $1.01
Average True Range (ATR) 0.16 0.04
MACD 0.04 0.01
Stochastic Oscillator 79.79 28.61

Price Performance

Historical Comparison
ASLE
LAB

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: